Neurogene stops Batten gene therapy after FDA denies request, dealing double dose of bad news Read more

Incyte's $750M buyout rocked by pause on key trial, asset cull Read more

Nearing potential FDA approval, BridgeBio shows additional positive data on ATTR-CM candidate acoramidis Read more

Lucy Nicholls

Charles Muriuki2024-11-28T09:43:07+00:00October 23, 2024|

Ultromics Recruitment Lead: “Their extensive market knowledge has helped us compete for talent and deliver a great candidate experience.”

Lucy Nicholls
Ultromics Recruitment Lead